-
1
-
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC
-
Bailé
n, Rebeca;
Pascual-Cascó
n, Marí
a Jesú
s;
Guerreiro, Manuel;
Ló
pez-Corral, Lucí
a;
Chinea, Anabelle;
Bermú
dez, Arancha;
Sampol, Antonia;
Heras, Inmaculada;
Garcí
a-Torres, Estefaní
a;
Torres, Melissa;
Roca, José
Rifó
n;
Herruzo, Beatriz;
Sanz, Jaime;
Fonseca, Marta;
Herrera, Pilar;
Colorado, Mercedes;
Bento, Leyre;
Ló
pez-Godino, Oriana;
Martí
n-Calvo, Carmen;
Ferná
ndez-Caldas, Paula;
Marcos-Jubilar, Marí
a;
Sá
nchez-Ortega, Isabel;
Solano, Carlos;
Noriega, Ví
ctor;
Humala, Karem;
Oarbeascoa, Gillen;
Dí
ez-Martí
n, José
Luis;
Kwon, Mi;
;
(Transplantation and cellular therapy,
v.28,
2022,
pp.204.e1-204.e10)
-
2
-
Low-Intensity Fludarabine, Cyclophosphamyde, Rituximab (FCR) as Front-Line Treatment for Follicular Lymphoma. Efficacy and Toxicity Profile of the Oral Versus Intravenous Administration.
-
Marin-Niebla, Ana;
Rios-Herranz, Eduardo;
de la Cruz Vicente Jr., Fá
atima;
Cerezuela, Paula;
Falantes, Jose Francisco;
Martino, Mariluz;
Espigado, Ildefonso;
Ispizua, Alvaro Urbano;
Hematology and Hemotherapy Department, Hospital Universitario Virgen del Rocí
o, Seville, Spain, Spain,;
Hematology Department, Hospital Universitario Virgen de Valme, Seville, Spain, Spain,;
Hematologí
a y Hemoterapia, Hospital Universitario Virgen del Rocio, Seville, Spain,;
Hematology and Hemotherapy Department, Hospital Universitario Virgen del Rocí
o, Seville, Spain, Spain,;
Hematology and Hemotherapy Department, Hospital Universitario Virgen del Rocí
o, Seville, Spain, Spain,;
Hematology and Hemotherapy Department, Hospital Universitario Virgen del Rocí
o, Seville, Spain, Spain,;
BM Failure Spanish Study Group (Pethema-GETH), Sevilla, Spain;
Hematology and Hemotherapy Department, Hospital Universitario Virgen del Rocí
o, Seville, Spain, Spain,;
(Blood,
v.114,
2009,
pp.2690-2690)
-
3
-
Treatment of steroid‐refractory chronic graft‐versus‐host disease with imatinib: Real‐life experience of the Spanish group of hematopoietic transplantation (GETH)
-
Parra Salinas, Ingrid;
Bermudez, Aranzazu;
Ló
pez Corral, Lucia;
Lopez Godino, Oriana;
Mó
les‐
Poveda, Paula;
Martí
n, Guillermo;
Costilla Barriga, Lissette;
Ferrá
Coll, Christelle;
Má
rquez‐
Malaver, Francisco;
Ortí
, Guillermo;
Zudaire Ripa, Maria Teresa;
Rifon, Jose;
Martinez, Carmen;
Miguel Servet University Hospital, Zaragoza, Spain;
Marqué
s de Valdecilla University Hospital, Santander, Spain;
Salamanca University Hospital, Salamanca, Spain;
Morales Meseguer General University Hospital, Murcia, Spain;
La FE Politecnic and University Hospital, Valencia, Spain;
Marqué
s de Valdecilla University Hospital, Santander, Spain;
Miguel Servet University Hospital, Zaragoza, Spain;
Germans Trials I Pujol Hospital, Badalona, Spain;
Virgen del Rocio University Hospital, Sevilla, Spain;
Vall d'Hebron University Hospital, Barcelona, Spain;
Hospital of Navarra, Pamplona, Spain
-
4
-
Autologous Stem Cell Transplantation Remains a Curative Option As Second Line Treatment for Patients with Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geth-TC/Geltamo Study
-
Bento, Leyre;
Gutié
rrez, Antonio;
Martí
nez, Carmen;
Ortí
, Consejo;
Sorribes, Marina;
Caballero, Ana Carolina;
Peñ
a, Marta;
Pé
rez, Ariadna;
Jimenez Ubieto, Ana;
Bastos-Oreiro, Mariana;
Ferná
ndez Caldas-Gonzá
lez, Paula;
Navarro, Belé
n;
Salcedo, Isabel;
Abrisqueta Costa, Pau;
Españ
ol, Ignacio;
Cornago, Javier;
Martí
n-Moro, Fernando;
Garcí
a, Lucí
a;
Gó
mez, Pilar;
Varela, Rosario;
Puente, Marí
a;
Zanabili, Joud;
Zudaire, Teresa;
Zeberio, Izaskun;
Del Campo, Raquel;
Gonzá
lez, Leslie;
Gonzalez-Sierra, Pedro;
Blá
zquez Goñ
i, Cristina;
Rovira, Jordina;
Sitges, Marta;
Franch, Mireia;
Cabero, Almudena;
Mussetti, Alberto;
Montoro, Juan;
Sampol Mayol, Antonia;
Sureda Balari, Anna Maria;
Caballero, Dolores;
Martí
n Garcí
a-Sancho, Alejandro;
1Hematology Department, Hospital Universitario Son Espases, IdISBa, Palma de Mallorca, Spain;
1Hematology Department, Hospital Universitario Son Espases, IdISBa, Palma de Mallorca, Spain;
2Hematology Department, Hospital Clinic, Barcelona, Spain;
3Hematology Department, Hospital La Fe, Valencia, Spain;
4Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain;
4Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain;
5Clinical Hematology Department, Institut Català
d'Oncologia-Hospitalet, IDIBELL, Barcelona, Spain;
6Hematology Department, Hospital Clí
nico de Valencia, Valencia, Spain;
7Hospital Universitario 12 de Octubre, MADRID, Spain;
8Hematology Department, Hospital General Universitario Gregorio Marañ
ó
n, Instituto de Investigació
n Sanitaria Gregorio Marañ
ó
n, Madrid, Spain;
8Hematology Department, Hospital General Universitario Gregorio Marañ
ó
n, Instituto de Investigació
n;
(Blood,
v.142,
2023,
pp.786-786)
1